Qiagen NV (NYSE:QGEN)
| 41.16 Delayed Data As of 3:59pm ET |  -0.07 / -0.17%Today’s Change | 34.74 Today|||52-Week Range 51.18 | -17.47% Year-to-Date |
Latest QGEN News | Press Releases
| Why Is Incyte (INCY) Down 1.8% Since Last Earnings Report? 11:31am / Zacks.com - Paid Partner Content | Qiagen (QGEN) Up 9.9% Since Last Earnings Report: Can It Continue? Nov 29 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 41.23 |
| Today’s open | 41.16 |
| Day’s range | 40.72 - 41.22 |
| Volume | 1,033,807 |
| Average volume (3 months) | 1,294,025 |
| Market cap | $9.3B |
Data as of 3:59pm ET, 11/30/2023
Growth & Valuation
| Earnings growth (last year) | -17.29% |
| Earnings growth (this year) | -11.31% |
| Earnings growth (next 5 years) | +4.82% |
| Revenue growth (last year) | -4.89% |
| P/E ratio | 28.4 |
| Price/Sales | 5.36 |
| Price/Book | 2.69 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| BRKRBruker Corp | -0.00 | -0.00% |
| RVTYRevvity Inc | -0.55 | -0.62% |
| BIOBio Rad Laboratories... | +0.40 | +0.13% |
| ---- |
Data as of 4:00pm ET, 11/30/2023
Financials
| Next reporting date | February 6, 2024 |
| EPS forecast (this quarter) | $0.57 |
| Annual revenue (last year) | $2.1B |
| Annual profit (last year) | $423.2M |
| Net profit margin | 19.76% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Venlo, Limburg |
Forecasts
